当前位置:产品中心>单抗/多抗

Anti-Influenza A virus HA/Hemagglutinin Reference Antibody|抗甲型流感病毒HA/血凝素参考抗体(靶标:甲型流感病毒血凝素)

货号:RB9T37015287
  • 价格:面议
  • 点击数:753
  

产品介绍

产品参数

产品描述Diridavumab, the alternative name, CR6261, is a human monoclonal antibody directed against influenza A hemagglutinin. The CR6261 antibody was first discovered by the Scripps Institute and Crucell, a Dutch biopharmaceutical company, and later developed by Janssen Pharmaceutical Companies of Johnson & Johnson under the trade name diridavumab. Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants).
形态Liquid
宿主种属Human
克隆性Monoclonal
抗体亚型IgG1, lambda
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1.41mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Influenza A virus
靶标HA/Hemagglutinin
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号P03455
别名CR-6261, CR6261, 1393659-46-5
备注For research use only. Not suitable for clinical or therapeutic use.